About Roelof Rongen
Roelof Rongen is CEO and director at Adolore Biotherapeutics.
Roelof Rongen first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Roelof Rongen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Roelof Rongen works with at each company, as listed on that company's latest Form D.
Adolore Biotherapeutics, Inc. · Form D, Sep 29, 2025
PB
Paul Barone
Executive officer, director and promoter
MR
Mark Rogers
Director
RL
Roy Levitt
Executive officer, director and promoter